|
|
Taiwan Academic Institutional Repository >
Browse by Title
|
Showing items 771421-771430 of 2348617 (234862 Page(s) Totally)
<< < 77138 77139 77140 77141 77142 77143 77144 77145 77146 77147 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2010 |
Sorafenib Overcomes Trail Resistance of Hepatocellular Carcinoma Cells through the Inhibition of Stat3
|
陳昆鋒; 黃祥博; 林育靖; 蕭崇瑋; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HUANG, HSIANG-PO; LIN, YU-CHIN; SHIAU, CHUNG-WAI; CHEN, PEI-JER; CHENG, ANN-LII |
| 臺大學術典藏 |
2018-09-10T08:04:03Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
HSIANG-PO HUANG; PEI-JER CHEN; Kuen-Feng Chen; ANN-LII CHENG |
| 臺大學術典藏 |
2021-07-03T03:34:40Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; Liu T.-H.; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; PEI-JER CHEN; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T01:54:12Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; Liu T.-H.; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-03-19T01:54:21Z |
Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3
|
Chen K.-F.; Tai W.-T.; TSUNG-HAO LIU; Huang H.-P.; Lin Y.-C.; Shiau C.-W.; Li P.-K.; Chen P.-J.; Cheng A.-L. |
| 義守大學 |
2016-11 |
Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model
|
John Chun-Hao Chen;Hui-Yen Chuang;Fei-Ting Hsu;Yi-Chen Chen;Yi-Chun Chien;Jeng-Jong Hwang |
| 臺北醫學大學 |
2014 |
Sorafenib Prolongs Skin Allograft Survival Through Upregulation of Treg and Autophagy-Related Mechanism In Vivo
|
Lin, Jiunn-Chang;Liu, Chien-Liang;Lee, Jie-Jen;Liu, Tsang-Pai;Ko, Wen-Ching;Wu, Chih-Hsiung;Chen, Yu-Jen |
| 國立臺灣大學 |
2014 |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen, Mei-Ling; Yan, Bo-Shiun; Lu, Wan-Chih; Chen, Mei-Huei; Yu, Sung-Liang; Yang, Pan-Chyr Cheng, Ann-Lii; 俞松良; 楊泮池; 陳美齡; 鄭安理; 顏伯勳 |
| 臺大學術典藏 |
2018-09-10T14:50:19Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen, M.-L. and Yan, B.-S. and Lu, W.-C. and Chen, M.-H. and Yu, S.-L. and Yang, P.-C. and Cheng, A.-L.; Chen, Mei-Ling;Yan, Bo-Shiun;Lu, Wan-Chih;Chen, Mei-Huei;Yu, Sung-Liang;Yang, Pan-Chyr
Cheng, Ann-Lii; 俞松良;楊泮池;陳美齡;鄭安理;顏伯勳; 俞松良;楊泮池;陳美齡;鄭安理;顏伯勳; Hsu, F.M.; SUNG-LIANG YU; Chen, Mei-Ling; Chen, Mei-Ling; Yan, Bo-Shiun; BO-SHIUN YAN; Hsu, F.M.; ANN-LII CHENG; Lu, Wan-Chih; Chen, Mei-Huei; Chen, Mei-Huei; Yu, Sung-Liang; Yang, Pan-Chyr
Cheng, Ann-Lii; 楊泮池 |
| 臺大學術典藏 |
2020-12-02T02:33:42Z |
Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity
|
Chen M.-L.;Yan B.-S.;Lu W.-C.;Chen M.-H.;Yu S.-L.;PAN-CHYR YANG;Cheng A.-L.; Chen M.-L.; Yan B.-S.; Lu W.-C.; Chen M.-H.; Yu S.-L.; PAN-CHYR YANG; Cheng A.-L. |
Showing items 771421-771430 of 2348617 (234862 Page(s) Totally)
<< < 77138 77139 77140 77141 77142 77143 77144 77145 77146 77147 > >>
View [10|25|50] records per page
|
